Phase II trial of docosahexaenoic acid-sodium salicylate conjugate [CAT 1004] in patients with inflammatory bowel disorders
Latest Information Update: 26 Jul 2022
At a glance
- Drugs Edasalonexent (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 13 Feb 2013 New trial record